Restore
BIOTECH / PATIENT-FACING
Restore is Tr1X’s patient recruitment site for their Phase 1/2 clinical trial in Crohn’s disease. It needed to do something most clinical trial sites fail at: make a scared, exhausted patient with treatment-refractory Crohn’s actually want to learn more.We designed the Restore experience from the ground up, covering brand naming, visual identity, content strategy, and web design, as a standalone identity nested within the Tr1X family. Warm, clear, and human. Clinical enough to be credible. Approachable enough to convert.
When patients are out of options, clarity is everything.
Treatment-refractory Crohn’s disease is brutal. By the time a patient qualifies for the RESTORE trial, they have already tried two or more approved therapies and watched them fail. They are exhausted, often hopeless, and deeply skeptical. They need information they can actually read and trust. Not a wall of regulatory text.
We designed the Restore site to prioritize plain language without dumbing down the science. Eligibility criteria are written to inform, not intimidate. The trial process is explained step by step, with visual cues that reduce anxiety. Every question a nervous patient might have is answered before they have to ask.
A distinct brand that still lives within the Tr1X family.
Restore needed its own identity. Warm and human, distinct from the technical rigor of the Tr1X corporate site. But it could not feel disconnected. Patients and clinicians needed to know this was a legitimate Tr1X program, not a third-party recruitment campaign.
We created a visual system for Restore that draws from Tr1X’s design language while carving out its own emotional register: earthy tones, rounded forms, and imagery that centers the patient rather than the platform. The result is a site that feels like care, and that makes the science feel like hope.
Built to recruit across 15 U.S. clinical sites.
The Restore site needed to work hard logistically. Fifteen clinical sites across the country, each with specific contacts and protocols. Eligibility requirements complex enough to filter meaningfully but not so intimidating that they drove qualified patients away.
We built a site with integrated eligibility screening, a map-based site locator, and a bilingual contact form designed to reduce friction at every step. The trial opened enrollment on schedule, across all fifteen sites simultaneously.
CASE STUDIES SUMMARY
A patient-first recruitment site for a Phase 1/2 clinical trial, designed to convert qualified Crohn’s patients into enrolled participants at fifteen U.S. sites.
Brand and Strategy
- Brand naming (RESTORE)
- Visual identity system
- Content strategy and plain language copywriting
Web Design
- UX strategy and information architecture
- Eligibility screening flow
- Bilingual responsive design
Visual Design
- Custom patient-facing illustration
- Icon system
- Site locator and trial map UI
